Phase I study of regorafenib and sildenafil in advanced solid tumors.

被引：0
|
作者：
Poklepovic, Andrew Stewart [1 ]
Gordon, Sarah W. [1 ]
McGuire, William P. [1 ]
Thacker, Leroy R. [1 ]
Deng, Xiaoyan [1 ]
Tombes, Mary Beth [1 ]
Shrader, Ellen [1 ]
Ryan, Alison A. [1 ]
Kmieciak, Maciej [1 ]
Dent, Paul [1 ]
机构：
[1] VCU Massey Canc Ctr, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3593
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
    Poklepovic, Andrew S.
    Gordon, Sarah W.
    Kothadia, Sejal
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Hudson, Daniel
    Bandyopadhyay, Dipankar
    Ryan, Alison A.
    Kmieciak, Maciej
    Smith, Steven
    Dent, Paul
    ANTI-CANCER DRUGS, 2024, 35 (05) : 450 - 458
  • [2] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors.
    Sandler, Alan
    Taylor, Matthew Hiram
    Urba, Walter John
    Omuro, Antonio Marcilio Padula
    Anderson, Barry Douglas
    Hansen, Daniel
    Fisher, Brenda
    Claeys, Alisa J.
    Greathouse, Amy
    McLean, Sean
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] A phase I study of PT-112 in advanced solid tumors.
    Karp, Daniel D.
    Camidge, D. Ross
    Bryce, Alan Haruo
    Jimeno, Jose
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [7] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [8] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [9] Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.
    Casanova, Michela
    Bautista, Francisco
    Hewson, Quentin Campbell
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld
    Canete, Adela
    Corradini, Nadege
    Ploeger, Bart
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John Woojune
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345